** Shares of Hims & Hers HIMS.N rise 43% to $40.73 premarket
** Novo Nordisk NOVOb.CO has partnered with the telehealth firm to sell its popular weight loss drug through a bundled offering on HIMS platform
** Starting this week, customers will get access to the offerings of all dose strengths of Wegovy and a membership at a price starting at $599 per month - HIMS
** HIMS says it will continue to offer personalized compounded versions of semaglutide, the active ingredient in Novo's Wegovy
** Earlier this month, HIMS said it plans to sell Eli Lilly's LLY.N Zepbound on its platform
** Up to last close, HIMS up 17.8% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.